nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydralazine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0798	0.463	CbGbCtD
Hydralazine—CYP3A4—Progesterone—uterine cancer	0.0528	0.306	CbGbCtD
Hydralazine—RYR2—myometrium—uterine cancer	0.0281	0.0775	CbGeAlD
Hydralazine—CYP3A4—Etoposide—uterine cancer	0.0236	0.137	CbGbCtD
Hydralazine—RYR2—smooth muscle tissue—uterine cancer	0.0212	0.0586	CbGeAlD
Hydralazine—RYR2—uterus—uterine cancer	0.0182	0.0503	CbGeAlD
Hydralazine—AOC3—myometrium—uterine cancer	0.0169	0.0467	CbGeAlD
Hydralazine—RYR2—female reproductive system—uterine cancer	0.0164	0.0452	CbGeAlD
Hydralazine—CYP3A4—Doxorubicin—uterine cancer	0.0161	0.0935	CbGbCtD
Hydralazine—RYR2—female gonad—uterine cancer	0.0149	0.0411	CbGeAlD
Hydralazine—RYR2—vagina—uterine cancer	0.0148	0.0409	CbGeAlD
Hydralazine—P4HA1—myometrium—uterine cancer	0.0135	0.0373	CbGeAlD
Hydralazine—AOC3—uterine cervix—uterine cancer	0.0132	0.0363	CbGeAlD
Hydralazine—AOC3—smooth muscle tissue—uterine cancer	0.0128	0.0353	CbGeAlD
Hydralazine—AOC3—decidua—uterine cancer	0.0125	0.0346	CbGeAlD
Hydralazine—AOC3—renal system—uterine cancer	0.0123	0.034	CbGeAlD
Hydralazine—AOC3—endometrium—uterine cancer	0.0119	0.0328	CbGeAlD
Hydralazine—AOC3—mammalian vulva—uterine cancer	0.0115	0.0318	CbGeAlD
Hydralazine—AOC3—uterus—uterine cancer	0.011	0.0303	CbGeAlD
Hydralazine—P4HA1—uterine cervix—uterine cancer	0.0105	0.029	CbGeAlD
Hydralazine—P4HA1—smooth muscle tissue—uterine cancer	0.0102	0.0282	CbGeAlD
Hydralazine—P4HA1—decidua—uterine cancer	0.01	0.0277	CbGeAlD
Hydralazine—AOC3—female reproductive system—uterine cancer	0.00986	0.0272	CbGeAlD
Hydralazine—P4HA1—renal system—uterine cancer	0.00984	0.0272	CbGeAlD
Hydralazine—P4HA1—endometrium—uterine cancer	0.00951	0.0263	CbGeAlD
Hydralazine—P4HA1—mammalian vulva—uterine cancer	0.0092	0.0254	CbGeAlD
Hydralazine—AOC3—female gonad—uterine cancer	0.00897	0.0248	CbGeAlD
Hydralazine—AOC3—vagina—uterine cancer	0.00891	0.0246	CbGeAlD
Hydralazine—P4HA1—uterus—uterine cancer	0.00876	0.0242	CbGeAlD
Hydralazine—P4HA1—female reproductive system—uterine cancer	0.00788	0.0218	CbGeAlD
Hydralazine—P4HA1—female gonad—uterine cancer	0.00717	0.0198	CbGeAlD
Hydralazine—P4HA1—vagina—uterine cancer	0.00713	0.0197	CbGeAlD
Hydralazine—AOC3—lymph node—uterine cancer	0.00577	0.0159	CbGeAlD
Hydralazine—P4HA1—lymph node—uterine cancer	0.00461	0.0127	CbGeAlD
Hydralazine—CYP3A4—renal system—uterine cancer	0.00261	0.0072	CbGeAlD
Hydralazine—Tremor—Progesterone—uterine cancer	0.00217	0.00467	CcSEcCtD
Hydralazine—Cardiac failure congestive—Etoposide—uterine cancer	0.00217	0.00467	CcSEcCtD
Hydralazine—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00217	0.00466	CcSEcCtD
Hydralazine—Ill-defined disorder—Progesterone—uterine cancer	0.00215	0.00463	CcSEcCtD
Hydralazine—Hepatomegaly—Epirubicin—uterine cancer	0.00215	0.00462	CcSEcCtD
Hydralazine—Anaemia—Progesterone—uterine cancer	0.00214	0.00461	CcSEcCtD
Hydralazine—Malaise—Progesterone—uterine cancer	0.00209	0.0045	CcSEcCtD
Hydralazine—CYP3A4—female reproductive system—uterine cancer	0.00209	0.00577	CbGeAlD
Hydralazine—Palpitations—Progesterone—uterine cancer	0.00205	0.00441	CcSEcCtD
Hydralazine—Neuritis—Epirubicin—uterine cancer	0.00204	0.00438	CcSEcCtD
Hydralazine—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00202	0.00434	CcSEcCtD
Hydralazine—Cardiac failure—Etoposide—uterine cancer	0.00202	0.00434	CcSEcCtD
Hydralazine—Hepatomegaly—Doxorubicin—uterine cancer	0.00199	0.00427	CcSEcCtD
Hydralazine—Myalgia—Progesterone—uterine cancer	0.00197	0.00424	CcSEcCtD
Hydralazine—Arthralgia—Progesterone—uterine cancer	0.00197	0.00424	CcSEcCtD
Hydralazine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00197	0.00423	CcSEcCtD
Hydralazine—Anxiety—Progesterone—uterine cancer	0.00197	0.00423	CcSEcCtD
Hydralazine—Agranulocytosis—Dactinomycin—uterine cancer	0.00196	0.00421	CcSEcCtD
Hydralazine—Discomfort—Progesterone—uterine cancer	0.00195	0.00419	CcSEcCtD
Hydralazine—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00195	0.00419	CcSEcCtD
Hydralazine—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00194	0.00417	CcSEcCtD
Hydralazine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00193	0.00415	CcSEcCtD
Hydralazine—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.0019	0.00407	CcSEcCtD
Hydralazine—Oedema—Progesterone—uterine cancer	0.00189	0.00407	CcSEcCtD
Hydralazine—Neuritis—Doxorubicin—uterine cancer	0.00189	0.00405	CcSEcCtD
Hydralazine—Hepatitis—Dactinomycin—uterine cancer	0.00188	0.00405	CcSEcCtD
Hydralazine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00186	0.00399	CcSEcCtD
Hydralazine—Tachycardia—Progesterone—uterine cancer	0.00185	0.00397	CcSEcCtD
Hydralazine—Blood disorder—Epirubicin—uterine cancer	0.00182	0.00391	CcSEcCtD
Hydralazine—Anorexia—Progesterone—uterine cancer	0.0018	0.00388	CcSEcCtD
Hydralazine—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.00385	CcSEcCtD
Hydralazine—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.00385	CcSEcCtD
Hydralazine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00178	0.00383	CcSEcCtD
Hydralazine—Cramp muscle—Etoposide—uterine cancer	0.00177	0.00381	CcSEcCtD
Hydralazine—Hypotension—Progesterone—uterine cancer	0.00177	0.0038	CcSEcCtD
Hydralazine—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00177	0.0038	CcSEcCtD
Hydralazine—Flushing—Dactinomycin—uterine cancer	0.00175	0.00376	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00172	0.00371	CcSEcCtD
Hydralazine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00172	0.00369	CcSEcCtD
Hydralazine—Paraesthesia—Progesterone—uterine cancer	0.0017	0.00365	CcSEcCtD
Hydralazine—Chills—Dactinomycin—uterine cancer	0.00169	0.00363	CcSEcCtD
Hydralazine—Dyspnoea—Progesterone—uterine cancer	0.00169	0.00363	CcSEcCtD
Hydralazine—Blood disorder—Doxorubicin—uterine cancer	0.00169	0.00362	CcSEcCtD
Hydralazine—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00168	0.00361	CcSEcCtD
Hydralazine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00167	0.0036	CcSEcCtD
Hydralazine—Dyspepsia—Progesterone—uterine cancer	0.00167	0.00358	CcSEcCtD
Hydralazine—Lacrimation increased—Epirubicin—uterine cancer	0.00165	0.00355	CcSEcCtD
Hydralazine—Decreased appetite—Progesterone—uterine cancer	0.00165	0.00354	CcSEcCtD
Hydralazine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.00351	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Progesterone—uterine cancer	0.00163	0.00351	CcSEcCtD
Hydralazine—Constipation—Progesterone—uterine cancer	0.00162	0.00348	CcSEcCtD
Hydralazine—Pancytopenia—Etoposide—uterine cancer	0.00162	0.00348	CcSEcCtD
Hydralazine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.00344	CcSEcCtD
Hydralazine—Neutropenia—Etoposide—uterine cancer	0.00159	0.00342	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00156	0.00336	CcSEcCtD
Hydralazine—Feeling abnormal—Progesterone—uterine cancer	0.00156	0.00335	CcSEcCtD
Hydralazine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.00331	CcSEcCtD
Hydralazine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.00329	CcSEcCtD
Hydralazine—Lacrimation increased—Doxorubicin—uterine cancer	0.00153	0.00328	CcSEcCtD
Hydralazine—Ill-defined disorder—Dactinomycin—uterine cancer	0.00152	0.00327	CcSEcCtD
Hydralazine—Anaemia—Dactinomycin—uterine cancer	0.00152	0.00326	CcSEcCtD
Hydralazine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.00325	CcSEcCtD
Hydralazine—Urticaria—Progesterone—uterine cancer	0.0015	0.00323	CcSEcCtD
Hydralazine—Body temperature increased—Progesterone—uterine cancer	0.0015	0.00322	CcSEcCtD
Hydralazine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.0032	CcSEcCtD
Hydralazine—Neuropathy peripheral—Etoposide—uterine cancer	0.00149	0.0032	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00318	CcSEcCtD
Hydralazine—Jaundice—Etoposide—uterine cancer	0.00148	0.00318	CcSEcCtD
Hydralazine—Malaise—Dactinomycin—uterine cancer	0.00148	0.00318	CcSEcCtD
Hydralazine—Leukopenia—Dactinomycin—uterine cancer	0.00147	0.00315	CcSEcCtD
Hydralazine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.00315	CcSEcCtD
Hydralazine—Agranulocytosis—Etoposide—uterine cancer	0.00142	0.00305	CcSEcCtD
Hydralazine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.00304	CcSEcCtD
Hydralazine—Myalgia—Dactinomycin—uterine cancer	0.0014	0.003	CcSEcCtD
Hydralazine—Hypersensitivity—Progesterone—uterine cancer	0.00139	0.003	CcSEcCtD
Hydralazine—Discomfort—Dactinomycin—uterine cancer	0.00138	0.00296	CcSEcCtD
Hydralazine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00293	CcSEcCtD
Hydralazine—Hypoaesthesia—Etoposide—uterine cancer	0.00136	0.00291	CcSEcCtD
Hydralazine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00291	CcSEcCtD
Hydralazine—Pruritus—Progesterone—uterine cancer	0.00134	0.00288	CcSEcCtD
Hydralazine—Oedema—Dactinomycin—uterine cancer	0.00134	0.00288	CcSEcCtD
Hydralazine—Thrombocytopenia—Dactinomycin—uterine cancer	0.00131	0.00282	CcSEcCtD
Hydralazine—Diarrhoea—Progesterone—uterine cancer	0.0013	0.00278	CcSEcCtD
Hydralazine—Lymphadenopathy—Epirubicin—uterine cancer	0.00129	0.00278	CcSEcCtD
Hydralazine—Anorexia—Dactinomycin—uterine cancer	0.00128	0.00274	CcSEcCtD
Hydralazine—Flushing—Etoposide—uterine cancer	0.00127	0.00272	CcSEcCtD
Hydralazine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00272	CcSEcCtD
Hydralazine—Hepatic function abnormal—Epirubicin—uterine cancer	0.00126	0.00272	CcSEcCtD
Hydralazine—Dizziness—Progesterone—uterine cancer	0.00125	0.00269	CcSEcCtD
Hydralazine—Vascular purpura—Epirubicin—uterine cancer	0.00123	0.00265	CcSEcCtD
Hydralazine—Chills—Etoposide—uterine cancer	0.00122	0.00263	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00122	0.00262	CcSEcCtD
Hydralazine—Cardiac failure congestive—Epirubicin—uterine cancer	0.00122	0.00262	CcSEcCtD
Hydralazine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00261	CcSEcCtD
Hydralazine—Vomiting—Progesterone—uterine cancer	0.0012	0.00259	CcSEcCtD
Hydralazine—Lymphadenopathy—Doxorubicin—uterine cancer	0.0012	0.00257	CcSEcCtD
Hydralazine—Renal failure acute—Epirubicin—uterine cancer	0.0012	0.00257	CcSEcCtD
Hydralazine—Rash—Progesterone—uterine cancer	0.00119	0.00257	CcSEcCtD
Hydralazine—Dermatitis—Progesterone—uterine cancer	0.00119	0.00256	CcSEcCtD
Hydralazine—Headache—Progesterone—uterine cancer	0.00119	0.00255	CcSEcCtD
Hydralazine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00252	CcSEcCtD
Hydralazine—Hepatic function abnormal—Doxorubicin—uterine cancer	0.00117	0.00251	CcSEcCtD
Hydralazine—Decreased appetite—Dactinomycin—uterine cancer	0.00116	0.0025	CcSEcCtD
Hydralazine—Purpura—Epirubicin—uterine cancer	0.00115	0.00246	CcSEcCtD
Hydralazine—Vascular purpura—Doxorubicin—uterine cancer	0.00114	0.00246	CcSEcCtD
Hydralazine—Muscle spasms—Etoposide—uterine cancer	0.00114	0.00245	CcSEcCtD
Hydralazine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.00244	CcSEcCtD
Hydralazine—Cardiac failure—Epirubicin—uterine cancer	0.00113	0.00243	CcSEcCtD
Hydralazine—Cardiac failure congestive—Doxorubicin—uterine cancer	0.00113	0.00242	CcSEcCtD
Hydralazine—Nausea—Progesterone—uterine cancer	0.00112	0.00242	CcSEcCtD
Hydralazine—Renal failure acute—Doxorubicin—uterine cancer	0.00111	0.00238	CcSEcCtD
Hydralazine—Feeling abnormal—Dactinomycin—uterine cancer	0.0011	0.00237	CcSEcCtD
Hydralazine—Ill-defined disorder—Etoposide—uterine cancer	0.0011	0.00237	CcSEcCtD
Hydralazine—Anaemia—Etoposide—uterine cancer	0.0011	0.00236	CcSEcCtD
Hydralazine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00234	CcSEcCtD
Hydralazine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00232	CcSEcCtD
Hydralazine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00232	CcSEcCtD
Hydralazine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00231	CcSEcCtD
Hydralazine—Malaise—Etoposide—uterine cancer	0.00107	0.0023	CcSEcCtD
Hydralazine—Leukopenia—Etoposide—uterine cancer	0.00106	0.00228	CcSEcCtD
Hydralazine—Purpura—Doxorubicin—uterine cancer	0.00106	0.00228	CcSEcCtD
Hydralazine—Body temperature increased—Dactinomycin—uterine cancer	0.00106	0.00227	CcSEcCtD
Hydralazine—Cardiac failure—Doxorubicin—uterine cancer	0.00105	0.00225	CcSEcCtD
Hydralazine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00219	CcSEcCtD
Hydralazine—Discomfort—Etoposide—uterine cancer	0.000998	0.00214	CcSEcCtD
Hydralazine—Hypersensitivity—Dactinomycin—uterine cancer	0.000986	0.00212	CcSEcCtD
Hydralazine—Thrombocytopenia—Etoposide—uterine cancer	0.000948	0.00204	CcSEcCtD
Hydralazine—Tachycardia—Etoposide—uterine cancer	0.000945	0.00203	CcSEcCtD
Hydralazine—Eosinophilia—Epirubicin—uterine cancer	0.000945	0.00203	CcSEcCtD
Hydralazine—Angina pectoris—Epirubicin—uterine cancer	0.00093	0.002	CcSEcCtD
Hydralazine—Anorexia—Etoposide—uterine cancer	0.000923	0.00198	CcSEcCtD
Hydralazine—Diarrhoea—Dactinomycin—uterine cancer	0.000916	0.00197	CcSEcCtD
Hydralazine—Pancytopenia—Epirubicin—uterine cancer	0.000907	0.00195	CcSEcCtD
Hydralazine—Hypotension—Etoposide—uterine cancer	0.000905	0.00194	CcSEcCtD
Hydralazine—Dysuria—Epirubicin—uterine cancer	0.000893	0.00192	CcSEcCtD
Hydralazine—Neutropenia—Epirubicin—uterine cancer	0.000893	0.00192	CcSEcCtD
Hydralazine—Eosinophilia—Doxorubicin—uterine cancer	0.000875	0.00188	CcSEcCtD
Hydralazine—Paraesthesia—Etoposide—uterine cancer	0.00087	0.00187	CcSEcCtD
Hydralazine—Weight decreased—Epirubicin—uterine cancer	0.000864	0.00186	CcSEcCtD
Hydralazine—Dyspnoea—Etoposide—uterine cancer	0.000863	0.00186	CcSEcCtD
Hydralazine—Angina pectoris—Doxorubicin—uterine cancer	0.00086	0.00185	CcSEcCtD
Hydralazine—Vomiting—Dactinomycin—uterine cancer	0.000851	0.00183	CcSEcCtD
Hydralazine—Rash—Dactinomycin—uterine cancer	0.000844	0.00181	CcSEcCtD
Hydralazine—Decreased appetite—Etoposide—uterine cancer	0.000842	0.00181	CcSEcCtD
Hydralazine—Pancytopenia—Doxorubicin—uterine cancer	0.000839	0.0018	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000836	0.0018	CcSEcCtD
Hydralazine—Neuropathy peripheral—Epirubicin—uterine cancer	0.000834	0.00179	CcSEcCtD
Hydralazine—Jaundice—Epirubicin—uterine cancer	0.00083	0.00178	CcSEcCtD
Hydralazine—Constipation—Etoposide—uterine cancer	0.000828	0.00178	CcSEcCtD
Hydralazine—Conjunctivitis—Epirubicin—uterine cancer	0.000827	0.00178	CcSEcCtD
Hydralazine—Neutropenia—Doxorubicin—uterine cancer	0.000826	0.00177	CcSEcCtD
Hydralazine—Dysuria—Doxorubicin—uterine cancer	0.000826	0.00177	CcSEcCtD
Hydralazine—Haematuria—Epirubicin—uterine cancer	0.000812	0.00174	CcSEcCtD
Hydralazine—Weight decreased—Doxorubicin—uterine cancer	0.000799	0.00172	CcSEcCtD
Hydralazine—Feeling abnormal—Etoposide—uterine cancer	0.000798	0.00171	CcSEcCtD
Hydralazine—Nausea—Dactinomycin—uterine cancer	0.000795	0.00171	CcSEcCtD
Hydralazine—Agranulocytosis—Epirubicin—uterine cancer	0.000794	0.00171	CcSEcCtD
Hydralazine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000772	0.00166	CcSEcCtD
Hydralazine—Urticaria—Etoposide—uterine cancer	0.000769	0.00165	CcSEcCtD
Hydralazine—Jaundice—Doxorubicin—uterine cancer	0.000768	0.00165	CcSEcCtD
Hydralazine—Body temperature increased—Etoposide—uterine cancer	0.000766	0.00165	CcSEcCtD
Hydralazine—Conjunctivitis—Doxorubicin—uterine cancer	0.000766	0.00165	CcSEcCtD
Hydralazine—Hepatitis—Epirubicin—uterine cancer	0.000764	0.00164	CcSEcCtD
Hydralazine—Hypoaesthesia—Epirubicin—uterine cancer	0.00076	0.00163	CcSEcCtD
Hydralazine—Haematuria—Doxorubicin—uterine cancer	0.000751	0.00161	CcSEcCtD
Hydralazine—Agranulocytosis—Doxorubicin—uterine cancer	0.000735	0.00158	CcSEcCtD
Hydralazine—Hypersensitivity—Etoposide—uterine cancer	0.000714	0.00153	CcSEcCtD
Hydralazine—Flushing—Epirubicin—uterine cancer	0.000709	0.00152	CcSEcCtD
Hydralazine—Hepatitis—Doxorubicin—uterine cancer	0.000707	0.00152	CcSEcCtD
Hydralazine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000703	0.00151	CcSEcCtD
Hydralazine—Chills—Epirubicin—uterine cancer	0.000686	0.00147	CcSEcCtD
Hydralazine—Pruritus—Etoposide—uterine cancer	0.000685	0.00147	CcSEcCtD
Hydralazine—Diarrhoea—Etoposide—uterine cancer	0.000663	0.00142	CcSEcCtD
Hydralazine—Flushing—Doxorubicin—uterine cancer	0.000656	0.00141	CcSEcCtD
Hydralazine—Dizziness—Etoposide—uterine cancer	0.00064	0.00138	CcSEcCtD
Hydralazine—Muscle spasms—Epirubicin—uterine cancer	0.00064	0.00137	CcSEcCtD
Hydralazine—Chills—Doxorubicin—uterine cancer	0.000634	0.00136	CcSEcCtD
Hydralazine—Ill-defined disorder—Epirubicin—uterine cancer	0.000617	0.00133	CcSEcCtD
Hydralazine—Vomiting—Etoposide—uterine cancer	0.000616	0.00132	CcSEcCtD
Hydralazine—Anaemia—Epirubicin—uterine cancer	0.000615	0.00132	CcSEcCtD
Hydralazine—Agitation—Epirubicin—uterine cancer	0.000611	0.00131	CcSEcCtD
Hydralazine—Rash—Etoposide—uterine cancer	0.000611	0.00131	CcSEcCtD
Hydralazine—Dermatitis—Etoposide—uterine cancer	0.00061	0.00131	CcSEcCtD
Hydralazine—Headache—Etoposide—uterine cancer	0.000607	0.0013	CcSEcCtD
Hydralazine—Malaise—Epirubicin—uterine cancer	0.0006	0.00129	CcSEcCtD
Hydralazine—Leukopenia—Epirubicin—uterine cancer	0.000595	0.00128	CcSEcCtD
Hydralazine—Muscle spasms—Doxorubicin—uterine cancer	0.000592	0.00127	CcSEcCtD
Hydralazine—Palpitations—Epirubicin—uterine cancer	0.000588	0.00126	CcSEcCtD
Hydralazine—Nausea—Etoposide—uterine cancer	0.000575	0.00124	CcSEcCtD
Hydralazine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000571	0.00123	CcSEcCtD
Hydralazine—Anaemia—Doxorubicin—uterine cancer	0.000569	0.00122	CcSEcCtD
Hydralazine—Arthralgia—Epirubicin—uterine cancer	0.000566	0.00122	CcSEcCtD
Hydralazine—Myalgia—Epirubicin—uterine cancer	0.000566	0.00122	CcSEcCtD
Hydralazine—Agitation—Doxorubicin—uterine cancer	0.000566	0.00122	CcSEcCtD
Hydralazine—Anxiety—Epirubicin—uterine cancer	0.000564	0.00121	CcSEcCtD
Hydralazine—Discomfort—Epirubicin—uterine cancer	0.00056	0.0012	CcSEcCtD
Hydralazine—Malaise—Doxorubicin—uterine cancer	0.000555	0.00119	CcSEcCtD
Hydralazine—Leukopenia—Doxorubicin—uterine cancer	0.000551	0.00118	CcSEcCtD
Hydralazine—Palpitations—Doxorubicin—uterine cancer	0.000544	0.00117	CcSEcCtD
Hydralazine—Oedema—Epirubicin—uterine cancer	0.000543	0.00117	CcSEcCtD
Hydralazine—Thrombocytopenia—Epirubicin—uterine cancer	0.000532	0.00114	CcSEcCtD
Hydralazine—Tachycardia—Epirubicin—uterine cancer	0.00053	0.00114	CcSEcCtD
Hydralazine—Myalgia—Doxorubicin—uterine cancer	0.000524	0.00113	CcSEcCtD
Hydralazine—Arthralgia—Doxorubicin—uterine cancer	0.000524	0.00113	CcSEcCtD
Hydralazine—Anxiety—Doxorubicin—uterine cancer	0.000522	0.00112	CcSEcCtD
Hydralazine—Discomfort—Doxorubicin—uterine cancer	0.000518	0.00111	CcSEcCtD
Hydralazine—Anorexia—Epirubicin—uterine cancer	0.000517	0.00111	CcSEcCtD
Hydralazine—Hypotension—Epirubicin—uterine cancer	0.000507	0.00109	CcSEcCtD
Hydralazine—Oedema—Doxorubicin—uterine cancer	0.000502	0.00108	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000495	0.00106	CcSEcCtD
Hydralazine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000492	0.00106	CcSEcCtD
Hydralazine—Tachycardia—Doxorubicin—uterine cancer	0.00049	0.00105	CcSEcCtD
Hydralazine—Paraesthesia—Epirubicin—uterine cancer	0.000487	0.00105	CcSEcCtD
Hydralazine—Dyspnoea—Epirubicin—uterine cancer	0.000484	0.00104	CcSEcCtD
Hydralazine—Anorexia—Doxorubicin—uterine cancer	0.000479	0.00103	CcSEcCtD
Hydralazine—Dyspepsia—Epirubicin—uterine cancer	0.000478	0.00103	CcSEcCtD
Hydralazine—Decreased appetite—Epirubicin—uterine cancer	0.000472	0.00101	CcSEcCtD
Hydralazine—Hypotension—Doxorubicin—uterine cancer	0.000469	0.00101	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000469	0.00101	CcSEcCtD
Hydralazine—Constipation—Epirubicin—uterine cancer	0.000464	0.000998	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000458	0.000983	CcSEcCtD
Hydralazine—Paraesthesia—Doxorubicin—uterine cancer	0.000451	0.000969	CcSEcCtD
Hydralazine—Dyspnoea—Doxorubicin—uterine cancer	0.000448	0.000962	CcSEcCtD
Hydralazine—Feeling abnormal—Epirubicin—uterine cancer	0.000447	0.000961	CcSEcCtD
Hydralazine—Dyspepsia—Doxorubicin—uterine cancer	0.000442	0.00095	CcSEcCtD
Hydralazine—Decreased appetite—Doxorubicin—uterine cancer	0.000437	0.000938	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000434	0.000932	CcSEcCtD
Hydralazine—Urticaria—Epirubicin—uterine cancer	0.000431	0.000927	CcSEcCtD
Hydralazine—Constipation—Doxorubicin—uterine cancer	0.00043	0.000923	CcSEcCtD
Hydralazine—Body temperature increased—Epirubicin—uterine cancer	0.000429	0.000922	CcSEcCtD
Hydralazine—Feeling abnormal—Doxorubicin—uterine cancer	0.000414	0.00089	CcSEcCtD
Hydralazine—Hypersensitivity—Epirubicin—uterine cancer	0.0004	0.000859	CcSEcCtD
Hydralazine—Urticaria—Doxorubicin—uterine cancer	0.000399	0.000858	CcSEcCtD
Hydralazine—Body temperature increased—Doxorubicin—uterine cancer	0.000397	0.000853	CcSEcCtD
Hydralazine—Pruritus—Epirubicin—uterine cancer	0.000384	0.000825	CcSEcCtD
Hydralazine—Diarrhoea—Epirubicin—uterine cancer	0.000371	0.000798	CcSEcCtD
Hydralazine—Hypersensitivity—Doxorubicin—uterine cancer	0.00037	0.000795	CcSEcCtD
Hydralazine—Dizziness—Epirubicin—uterine cancer	0.000359	0.000771	CcSEcCtD
Hydralazine—Pruritus—Doxorubicin—uterine cancer	0.000355	0.000764	CcSEcCtD
Hydralazine—Vomiting—Epirubicin—uterine cancer	0.000345	0.000742	CcSEcCtD
Hydralazine—Diarrhoea—Doxorubicin—uterine cancer	0.000344	0.000739	CcSEcCtD
Hydralazine—Rash—Epirubicin—uterine cancer	0.000342	0.000736	CcSEcCtD
Hydralazine—Dermatitis—Epirubicin—uterine cancer	0.000342	0.000735	CcSEcCtD
Hydralazine—Headache—Epirubicin—uterine cancer	0.00034	0.000731	CcSEcCtD
Hydralazine—Dizziness—Doxorubicin—uterine cancer	0.000332	0.000714	CcSEcCtD
Hydralazine—Nausea—Epirubicin—uterine cancer	0.000322	0.000693	CcSEcCtD
Hydralazine—Vomiting—Doxorubicin—uterine cancer	0.000319	0.000686	CcSEcCtD
Hydralazine—Rash—Doxorubicin—uterine cancer	0.000317	0.000681	CcSEcCtD
Hydralazine—Dermatitis—Doxorubicin—uterine cancer	0.000316	0.00068	CcSEcCtD
Hydralazine—Headache—Doxorubicin—uterine cancer	0.000315	0.000676	CcSEcCtD
Hydralazine—Nausea—Doxorubicin—uterine cancer	0.000298	0.000641	CcSEcCtD
